The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Development, Reliability and Validity of the Telerehabilitation Usability Questionnaire- TrUQ

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05970939
Recruitment Status : Not yet recruiting
First Posted : August 2, 2023
Last Update Posted : August 3, 2023
Sponsor:
Information provided by (Responsible Party):
Kader Eldemir, T.C. ORDU ÜNİVERSİTESİ

Brief Summary:
Neurological diseases are central nervous system diseases that cause an increase in the level of disability and limitations in daily life. Multiple Sclerosis (MS), stroke, and Parkinson's Disease (PD) are among the most common apparent neurological diseases, and epidemiological studies show that their prevalence has increased over time worldwide. Although MS, stroke, and PD have different causes and neurological aspects, they generally cause motor, sensory, and/or cognitive impairments, leading to restriction of the individual's activities and participation. Today, physiotherapy and rehabilitation approaches together with optimal medical and surgical treatment are the cornerstones of treatment for these diseases. Recently, it has been stated that various telerehabilitation interventions in the field of physiotherapy and rehabilitation may be an additional option to the rehabilitation approaches applied in the clinic. On the other hand, It is important to evaluate the level of usability in expanding the usability of telerehabilitation services and determining the best telerehabilitation service. For this reason, there is a need for questionnaires investigating the satisfaction level of physiotherapy and rehabilitation applied through telerehabilitation.

Condition or disease Intervention/treatment
Neurological Disease Other: Development of the Telerehabilitation Usability Questionnaire

Detailed Description:
Questionnaire items will be created in two stages. First, 5 experts will independently review the literature on "telerehabilitation" and "usability". In addition, these experts will be asked to create a pool of questions based on their experiences in telerehabilitation and by taking the opinions of patients receiving telerehabilitation about usability. Then, 5 experts will come together and obtain a single question pool containing the questions they deem important in their question pool. The second step will involve scaling the elements. In this study, scale items will be scored on a five-point Likert scale, ranging from 1, strongly disagree to 5, strongly agree. Then, it will be applied to a pilot group of 10 people and it will be evaluated whether the items prepared by the experts are understood by the patients. In line with the expert opinion and the result of the pilot study, the final version of the scale will be decided and applied to MS, PD, and stroke patients who make up the study group. Finally, the validity and reliability of the questionnaire will be calculated.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Development, Reliability and Validity of the Telerehabilitation Usability Questionnaire- TrUQ in Neurological Diseases
Estimated Study Start Date : July 28, 2023
Estimated Primary Completion Date : August 28, 2023
Estimated Study Completion Date : August 28, 2023

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Telerehabilitation Usability
Telerehabilitation Usability Group
Other: Development of the Telerehabilitation Usability Questionnaire
This study will be examined the development, validity, and reliability of the Telerehabilitation Usability Questionnaire in patients with MS.




Primary Outcome Measures :
  1. Telerehabilitation Usability Questionnaire in patients with Neurological disease [ Time Frame: Baseline ]
    Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale

  2. Telerehabilitation Usability Questionnaire in patients with Neurological disease-Second [ Time Frame: he second assessment will be conducted after the one week ]
    Patients get a minimum of 0 points (best condition) and a maximum of 4 points (worst condition) for each question on this scale



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Neurological patients receiving physiotherapy and rehabilitation via telerehabilitation
Criteria

Inclusion Criteria:

  • Voluntarily participate in research to accept
  • Mini-Mental Test score more than or equal 24
  • Previously receiving physical therapy through telerehabilitation

Exclusion Criteria:

  • Any visual, hearing, and perception problems that may affect the answering the questionnaire items

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05970939


Contacts
Layout table for location contacts
Contact: Kader Eldemir +9 0452 226 52 48 fztkader2015@gmail.com

Locations
Layout table for location information
Turkey
Gazi University
Ankara, Turkey
Sponsors and Collaborators
Gazi University
Additional Information:
Publications:
Layout table for additonal information
Responsible Party: Kader Eldemir, principal investigator, T.C. ORDU ÜNİVERSİTESİ
ClinicalTrials.gov Identifier: NCT05970939    
Other Study ID Numbers: ND-Development-TrUQ
First Posted: August 2, 2023    Key Record Dates
Last Update Posted: August 3, 2023
Last Verified: August 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Kader Eldemir, T.C. ORDU ÜNİVERSİTESİ:
Multiple Sclerosis
Parkinson Disease
Stroke
Usability
Telerehabilitation
Additional relevant MeSH terms:
Layout table for MeSH terms
Nervous System Diseases